NSC |
Compound |
Enrichment |
Correlation |
NSC 724330 |
Aminopyrimidine-CH3 |
0.038506707102734 |
-0.32199109 |
NSC 726262 |
1,1'-{[(bispropane-1,N-diyl)piperzine]dioxy}bis[(11aS)-7-met hoxy-1,2,3,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepi n-5-one |
0.038506707102734 |
-0.043278921 |
NSC 732837 |
1-[4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrolyla mino)phenylcarboxamido]-4-chloro-3-trifluoromethylbenzene |
0.038506707102734 |
-0.05411983 |
NSC 743220 |
N2-(4-fluorophenyl)-N3-(2-methoxyphenyl)-5-oxo-7-propyl-5H-[ 1,3]thiazolo[3,2-a]pyrimidine-2,3-dicarboxamide |
0.038506707102734 |
0.48318821 |
NSC 743862 |
Null |
0.038506707102734 |
-0.26578813 |
NSC 747451 |
3,19-Benzylidine-14-deoxy-11,12-didehydroandrographolide |
0.038506707102734 |
-0.096038058 |
NSC 117915 |
1H-Indole-2,3-dione, 5-methyl-,3-[2-(2-nitrophenyl)hydrazone] |
0.0385067071027343 |
0.38990838 |
NSC 150862 |
BLEOMYCIN FRACTION BLM-HPE |
0.0385067071027343 |
0.376945 |
NSC 175633 |
4(1H)-Quinazolinone, 2-(2-chlorophenyl)-2,3-dihydro- |
0.0385067071027343 |
-0.18459752 |
NSC 180973 |
Tamoxifen citrate |
0.0385067071027343 |
-0.28455317 |